Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK5 | Q00535 | 1/20 | 0.40 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.40 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.35 |
| ▸ | MBOAT4 | Q96T53 | 2/20 | 0.33 |
| ▸ | RET | P07949 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | CAMK1D | Q8IU85 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL332530 | 1.00 | CDK5 (0.40) | CDK5CDK5R1NR1I3GRIN1GRIN2B | |
| SCHEMBL901326 | 1.00 | CDK5 (0.40) | CDK5CDK5R1NR1I3GRIN1GRIN2B | |
| Water SCHEMBL1070875 | 0.98 | CDK5 (0.39) | CDK5CDK5R1NR1I3GRIN1GRIN2B | |
| Ammonia Solution, Strong SCHEMBL2074263 | 0.98 | CDK5 (0.39) | CDK5CDK5R1NR1I3GRIN1GRIN2B | |
| SCHEMBL27882040 | 0.98 | CDK5 (0.39) | CDK5CDK5R1NR1I3GRIN1GRIN2B | |
| Water SCHEMBL1888091 | 0.98 | CDK5 (0.39) | CDK5CDK5R1NR1I3GRIN1GRIN2B | |
| SCHEMBL789094 | 0.98 | CDK5 (0.39) | CDK5CDK5R1NR1I3GRIN1GRIN2B | |
| Water SCHEMBL3935755 | 0.98 | CDK5 (0.39) | CDK5CDK5R1NR1I3GRIN1GRIN2B | |
| Cyanide SCHEMBL28515924 | 0.95 | CDK5 (0.38) | CDK5CDK5R1NR1I3GRIN1GRIN2B | |
| SCHEMBL17856475 | 0.94 | NR1I3 (0.40) | CDK5CDK5R1NR1I3GRIN1GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 69081 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146291-A1 | METHOD FOR PREDICTING A RESPONSE TO SYSTEMIC TREATMENT IN A HORMONE RECEPTOR-POSITIVE (HR+) AND HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HER2-) BREAST CANCER PATIENT | GBG FORSCHUNGS GMBH (DE) | 2026-05-28 | — | — | US | claimed |
| EP-4746926-A2 | PSMA-TARGETING RADIOLIGAND TREATMENT REGIMEN | Novartis AG (CH) | 2026-05-27 | — | — | EP | claimed |
| EP-4748453-A2 | METHODS OF TREATING LOCALLY ADVANCED OR METASTATIC BREAST CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES | F. Hoffmann-La Roche AG (CH) | 2026-05-27 | — | — | EP | claimed |
| EP-4071174-B1 | METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB | ASTRAZENECA AB (SE) | 2026-05-27 | — | — | EP | claimed |
| EP-4747388-A1 | RECOMBINANT BACTERIAL CELL CAPABLE OF EXPRESSING A HETEROLOGOUS EXTRACELLULAR MATRIX (ECM) DEGRADING POLYPEPTIDE USING A TUMOUR-INDUCIBLE PROMOTER | NEOBE THERAPEUTICS LTD (GB) | 2026-05-27 | — | — | EP | claimed |
| US-12636384-B2 | Nanoemulsion with porphyrin shell | UNIVERSITY HEALTH NETWORK (CA) | 2026-05-26 | — | — | US | claimed |
| CN-117180264-B | Application of schisandrin B in preparing analgesic | Mengyang Pharmaceutical (Shanghai) Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122094689-A | Combination therapy of diacylglycerol kinase (DGK) alpha inhibitors with other therapies | — | 2026-05-26 | — | — | CN | claimed |
| US-12636379-B2 | Microbubble-chemotherapeutic agent complex for sonodynamic therapy | Sonotarg Limited (GB) | 2026-05-26 | — | — | US | claimed |
| CN-122075734-A | Conjugates comprising tetrapeptides, methods of making, intermediates and uses thereof | — | 2026-05-26 | — | — | CN | claimed |
| WO-1992009589-A1 | METHOD FOR PREPARING TAXANE DERIVATIVES, NOVEL DERIVATIVES THEREBY OBTAINED AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | RHONE-POULENC RORER S.A. (FR) | 1992-06-11 | — | — | WO | claimed |
| WO-1992007842-A1 | METHOD FOR THE ISOLATION AND PURIFICATION OF TAXANE DERIVATIVES | UNIVERSITY OF FLORIDA (US) | 1992-05-14 | — | — | WO | claimed |
| WO-1991017976-A1 | PROCESS FOR THE ENANTIOSELECTIVE PREPARATION OF PHENYLISOSERIN DERIVATIVES | RHONE-POULENC RORER S.A. (FR) | 1991-11-28 | — | — | WO | claimed |
| WO-1991017977-A1 | PROCESS FOR THE STEREOSELECTIVE PREPARATION OF PHENYLISOSERIN DERIVATIVES | RHONE-POULENC RORER S.A. (FR) | 1991-11-28 | — | — | WO | claimed |
| WO-1991013066-A2 | METHOD FOR PREPARING CIS-β-PHENYLGLYCIDIC-(2R,3R) ACID | RHONE-POULENC RORER S.A. (FR) | 1991-09-05 | — | — | WO | claimed |
| WO-1991013053-A1 | DERIVATIVE OF β-PHENYLISOSERINE, PREPARATION AND UTILISATION THEREOF | RHONE-POULENC RORER S.A. (FR) | 1991-09-05 | — | — | WO | claimed |
| US-5019504-A | Production of taxol or taxol-like compounds in cell culture | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1991-05-28 | — | — | US | claimed |
| EP-0414610-A1 | Process for the enantioselective preparation of phenylisoserine derivatives | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1991-02-27 | — | — | EP | claimed |
| EP-0336840-A1 | Process for the preparation of taxol | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1989-10-11 | — | — | EP | claimed |
| EP-0336841-A1 | Process for the preparation of baccatin III derivatives and of desacetyl-10 baccatin III | RHONE-POULENC SANTE (FR) | 1989-10-11 | — | — | EP | claimed |